FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934


For the month of May 2011

Commission File Number: 001-15152


SYNGENTA AG
(Translation of registrant’s name into English)

Schwarzwaldallee 215
4058 Basel
Switzerland
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F
X
 
Form 40-F
 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes
   
No
X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes
   
No
X

Indicate by check mark whether by furnishing the information contained in this Form, the Registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes
   
No
X

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
 


 
 

 
 
Re:                                SYNGENTA AG

Press Release:
"Syngenta launches new seed treatment”

Herewith we furnish a press release related to Syngenta AG. The full text of the press release is the following:
# # #

 
 

 
 
 
Syngenta International AG
 
Media Office
CH-4002 Basel
Switzerland
Tel:                     +41 61 323 23 23
Fax:                    +41 61 323 24 24
 
www.syngenta.com
Media contacts:
 
Médard Schoenmaeckers
Switzerland    +41 61 323 2323
 
Michael Edmond Isaac
Switzerland    +41 61 323 2323
 
Analyst/Investor contacts:
 
Jennifer Gough
Switzerland         +41 61 323 5059
USA                     +1 202 737 6521
 
Claire Hinshelwood
Switzerland        +41 61 323 7812
USA                    +1 202 737 6520
 
 
 
Basel, Switzerland, May 18, 2011

Syngenta launches new seed treatment

·  
First compound developed specifically for seed treatment uses
 
·  
Optimizes performance of root systems under a wide range of conditions
 
·  
First registration in Argentina for use on cereals
 

Syngenta announced today the launch of VIBRANCE™, a proprietary seed treatment fungicide based on the new active ingredient sedaxane. VIBRANCE, which has been tailored specifically for the seed treatment market, protects major crops against a wide range of diseases carried in soil and air as well as against seed infection. Its properties also result in outstanding protection of the entire plant root system.

John Atkin, Syngenta COO, said: “Research is increasingly focusing on the ability of roots to efficiently use water and nutrients as a key to further improvements in crop productivity. VIBRANCE is a major step towards integrated root health solutions and will play an important role in enforcing Syngenta’s global leadership position in seed treatment.”

Recent results in the field demonstrate that VIBRANCE delivers enhanced root health leading to improved crop performance under a wide range of conditions. VIBRANCE is now available in Argentina for the coming growing season. It will be combined with other Syngenta Seed Care compounds as a complete solution for cereals. Further registrations across all major crops worldwide are expected over the next two years.
 
Syngenta is one of the world's leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
 
Syngenta – May 18, 2011 / Page 1 of 2

 
 

 

 
 
 
 
 
 
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.
 
Syngenta – May 18, 2011 / Page 2 of 2
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
   
SYNGENTA AG
 
 
 
Date:
May 18, 2011
 
By:
/s/ Tobias Meili
 
       
Name:
Tobias Meili
 
     
 
Title:
Head Corporate Legal Affairs
 
             
             
             
             
     
By:
/s/ Brigitte Benz
 
       
Name:
Brigitte Benz
 
     
 
Title:
Deputy Head Shareholder Services & Group Administration